| __timestamp | Novo Nordisk A/S | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 26760000000 | 17992000000 |
| Thursday, January 1, 2015 | 32169000000 | 22400000000 |
| Friday, January 1, 2016 | 32339000000 | 23910000000 |
| Sunday, January 1, 2017 | 32124000000 | 23813000000 |
| Monday, January 1, 2018 | 33313000000 | 24694000000 |
| Tuesday, January 1, 2019 | 35830000000 | 23557000000 |
| Wednesday, January 1, 2020 | 36886000000 | 25436000000 |
| Friday, January 1, 2021 | 41058000000 | 24586000000 |
| Saturday, January 1, 2022 | 50684000000 | 27295000000 |
| Sunday, January 1, 2023 | 61598000000 | 34205000000 |
| Monday, January 1, 2024 | 67377000000 | 28113000000 |
Unlocking the unknown
In the world of pharmaceuticals and retail, Novo Nordisk A/S and Walgreens Boots Alliance, Inc. stand as titans, each with distinct strategies reflected in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Novo Nordisk's SG&A expenses surged by approximately 130%, highlighting a robust investment in growth and market expansion. In contrast, Walgreens Boots Alliance exhibited a steadier increase of about 44% over the same period, indicating a more conservative approach.
Novo Nordisk's aggressive spending, peaking at over 61 billion in 2023, underscores its commitment to innovation and market penetration. Meanwhile, Walgreens' consistent rise to nearly 28 billion in 2024 suggests a focus on operational efficiency and strategic positioning. This comparison not only reveals their financial strategies but also offers insights into their future trajectories in an ever-evolving market landscape.
Novo Nordisk A/S or Vertex Pharmaceuticals Incorporated: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Novo Nordisk A/S vs ImmunityBio, Inc. Trends and Insights
Breaking Down SG&A Expenses: Novo Nordisk A/S vs Soleno Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or MorphoSys AG
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or MannKind Corporation
SG&A Efficiency Analysis: Comparing Novo Nordisk A/S and HUTCHMED (China) Limited
Cost Management Insights: SG&A Expenses for Pfizer Inc. and Walgreens Boots Alliance, Inc.
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Cytokinetics, Incorporated
Comparing SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ionis Pharmaceuticals, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Walgreens Boots Alliance, Inc. and Merus N.V.
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Bausch Health Companies Inc.
Walgreens Boots Alliance, Inc. or Galapagos NV: Who Manages SG&A Costs Better?